RIGL   $45.58  -0.59% Market Open

Rigel Pharmaceuticals, Inc.

EMA (20): 2026-09-14 the price crossed down the moving average line and formed a short-term downside trend.

EMA (50): 2026-05-28 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2026-06-11 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.

Trend Type turning up
Power slow
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -1.92%
EMA (20) date of signal Sept. 14, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 48.02%
EMA (50) date of signal May 28, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 38.65%
EMA (100) date of signal June 11, 2026, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal Sept. 16, 2026, 3 a.m.
MACD Signals bearish reversal
MACD Yield -6.10%
MACD date of signal Sept. 8, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield -5.92%
Stochastic date of signal Sept. 10, 2026, 3 a.m.
Updated Sept. 17, 2026, 11:02 p.m.